Endothelin receptor antagonists in the treatment of prostate cancer.
Nelson
J B
JB
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000077868:Atrasentan; D001859:Bone Neoplasms / Q000556:secondary; D001862:Bone Resorption / Q000378:metabolism; D018450:Disease Progression; D065128:Endothelin Receptor Antagonists; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011759:Pyrrolidines; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D065128:Endothelin Receptor Antagonists; D011759:Pyrrolidines; D000077868:Atrasentan